The important role for intravenous iron in perioperative patient blood management in major abdominal surgery

Annals of Surgery

Volumn 264, Issue 1, 2016, Pages 41-46

  Froessler, Bernd ^a,b   Palm, Peter ^a   Weber, Ingo ^a   Hodyl, Nicolette A ^b   Singh, Rajvinder ^a,c   Murphy, Elizabeth M ^a  

^a LYELL MCEWIN HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

intravenous iron; iron deficiency anemia; outcomes; red blood cell transfusion; surgery

Indexed keywords

ANALGESIC AGENT; HEMOGLOBIN; IRON; FERRIC CARBOXYMALTOSE; FERRIC ION; MALTOSE;

ABDOMINAL SURGERY; ADULT; ARTICLE; BACKACHE; CONTROLLED STUDY; DIZZINESS; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME; ABDOMINAL CAVITY; AGED; ANALOGS AND DERIVATIVES; ANEMIA, IRON-DEFICIENCY; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BODY MASS; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; POSTOPERATIVE CARE; PROCEDURES; SURGERY;

ABDOMINAL CAVITY; AGED; ANEMIA, IRON-DEFICIENCY; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BODY MASS INDEX; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MALTOSE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE CARE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84955578569     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001646     Document Type: Article

References (47)

1. McLean E, Cogswell M, Egli I, et al.Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009 12 444-454
2. Beattie WS, Karkouti K, Wijeysundera DN, et al. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology. 2009; 110: 574-581
3. Hamilton W, Lancashire R, Sharp D, et al. The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. Br J Cancer. 2008; 98: 323-327
4. Browning RM, Trentino K, Nathan EA, et al. Preoperative anaemia is common in patients undergoing major gynaecological surgery and is associated with a fivefold increased risk of transfusion. Aust N Z J Obstet Gynaecol. 2012; 52: 455-459
5. Hreinsson JP, Jonasson JG, Bjornsson ES. Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study. Aliment Pharmacol Ther. 2014; 39: 77-84
6. Gupta PKMD, Sundaram AMMPH, MacTaggart JNMD, et al. Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing elective vascular operations. Ann Surg. 2013; 258: 1096-1102
7. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 47-52
8. Sanders J, Keogh BE, Van der Meulen J, et al. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery. J Clin Epidemiol. 2012; 65: 423-433
9. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-Analysis. Ann Surg. 2012; 256: 235-244
10. FerrarisVA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg. 2012; 147: 49-55
11. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011; 114: 283-292
12. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012; 4: CD002042
13. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340: 409-417
14. National Blood Authority. Patient blood management guidelines: Module 2 Perioperative 2012. Available at: http://www. nba.gov.au/guidelines/module2/po-v1a.pdf. Accessed August 15, 2015
15. Leal-Noval SR, Munoz M, Asuero M, et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the ''Seville Document''. Blood Transfus. 2013; 11: 585-610
16. Gombotz H, Rehak PH, Shander A, et al. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion. 2014; 54: 2646-2657
17. Munoz M, Gomez-Ramirez S, Campos A, et al. Pre-operative anaemia prevalence, consequences and approaches to management. Blood Transfus. 2015; 1-10
18. Shander A. Preoperative anemia and its management. Transfus Apher Sci. 2014; 50: 13-15
19. Froessler B, Papendorf D. Intravenous iron sucrosean effective and attractive modality for perioperative anaemia management. Anaesth Intensive Care. 2010; 38: 960-962
20. Okuyama M, Ikeda K, Shibata T, et al. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today. 2005; 35: 36-40
21. Muñoz M, Breymann C, García-Erce JA, et al. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang. 2008; 94: 172-183
22. Froessler B, Tufanaru C, Cyna A, et al. Preoperative anaemia management with intravenous iron: a systematic review. JBI Database Syst Rev Implement Rep. 2013; 11: 33
23. Gasche C. Intravenous iron in inflammatory bowel disease. Semin Hematol. 2006; 43: S18-S22
24. Lachance K, Savoie M, Bernard M, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother. 2011; 45: 764-770
25. Schroder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005; 100: 2503-2509
26. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007; 13: 1545-1553
27. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus. 2014; 12: 296-300
28. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473-483
29. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004; 40: 2293-2306
30. Dallman PR. Iron deficiency: does it matter?. J Intern Med. 1989; 226: 367-372
31. Isbister JP, Shander A, Spahn DR, et al. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev. 2011; 25: 89-101
32. Tinmouth A, Macdougall L, Fergusson D, et al. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med. 2005; 165: 845-852
33. Isbister JP. The three-pillar matrix of patient blood management. ISBT Sci Series. 2015; 10: 286-294
34. Bolton-Maggs PH, Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol. 2013; 163: 303-314
35. Kickler TS, Smith B, Bell W, et al. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test. Transfusion. 1985; 25: 401-405
36. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, et al. Perioperative anemia management in colorectal cancer patients: a pragmatic approach. World J Gastroenterol. 2014; 20: 1972-1985
37. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011; 378: 1396-1407
38. Theusinger OM, Felix C, Spahn DR. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol. 2012; 25: 59-65
39. Abdelsattar ZMMDM, Hendren SMDMPH, Wong SLMDMS, et al. Variation in transfusion practices and the effect on outcomes after noncardiac surgery. Ann Surg. 2015; 262: 1-6
40. Isbister JP. Strategies for avoiding or minimizing homologous blood transfusion: a sequel to the AIDS scare. Med J Aust. 1985; 142: 596-599
41. Spahn DR, Theusinger OM, Hofmann A. Patient blood management is a winwin: a wake-up call. Br J Anaesth. 2012; 108: 889-892
42. Spahn DR, Zacharowski K. Non-Treatment of preoperative anaemia is substandard clinical practice. Br J Anaesth. 2015
43. ShanderA, Goodnough LT, Javidroozi M, et al. Iron deficiency anemia-bridging the knowledge and practice gap. Transfus Med Rev. 2014; 28: 156-166
44. Munoz M, Gomez-Ramirez S, Kozek-Langeneker S, et al. 'Fit to fly': overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth. 2015; 115: 15-24
45. Frank SM, Ejaz A, Pawlik TM. Blood transfusion strategy and clinical outcomes. Ann Surg. 2015; 262: 7-8
46. Beris P, Munoz M, Garcia-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008; 100: 599-604
47. Munoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-Term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014; 54: 289-299